As of April 19, 2025, Orphazyme A/S (ORPHA.CO) has a market cap of $7.134 million USD. According to our data, Orphazyme A/S is ranked No.8933 in global market value.
Year | Market Cap | %Change |
---|---|---|
Oct 29, 2024 | $7.13 M |
-21.22%
|
Dec 29, 2023 | $8.47 M |
51.14%
|
Dec 30, 2022 | $5.60 M |
-94.87%
|
Dec 30, 2021 | $0.11 B |
-74.43%
|
Dec 30, 2020 | $0.43 B |
-7.32%
|
Dec 30, 2019 | $0.46 B |
67.01%
|
Dec 28, 2018 | $0.28 B |
-42.96%
|
Dec 29, 2017 | $0.48 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Ionis Pharmaceuticals
IONS
|
$4.51 B |
-0.000 M
|
![]() USA
|
![]() Sarepta Therapeutics
SRPT
|
$5.22 B |
0.000 M
|
![]() USA
|
![]() Amicus Therapeutics
FOLD
|
$2.10 B |
-0.000 M
|
![]() USA
|
![]() BioMarin Pharmaceutical
BMRN
|
$11.35 B |
0.000 M
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
![]() Ultragenyx
RARE
|
$3.35 B |
0.000 M
|
![]() USA
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
![]() Takeda Pharmaceutical
TAK
|
$46.30 B |
0.000 M
|
![]() Japan
|
![]() CSL
CSL.AX
|
$73.92 B |
0.002 M
|
![]() Australia
|
Market Cap | = | ORPHA.CO Stock Price | * | ORPHA.CO Shares Outstanding |
= | $171.02 | * | 0.04 M | |
= | $7.13 M |